Skip to main content
. 2017 Mar 1;11(3):UC04–UC07. doi: 10.7860/JCDR/2017/21437.9434

[Table/Fig-2]:

Baseline characteristics and adverse effects in the patients.

Patients Characteristics Placebo (n=23)
(mean±sd)
Propofol (n=23)
(mean±sd)
Ketamine (n=23)
(mean±sd)
Ketofol (n=23) (mean±sd) p-value
Age/year 26.5±1.7 27.5±2.5 27.9±1.6 28.1±2.4 0.06*
Surgery duration/min 67.5±2 65.4±3.7 67.1±5.1 66.1±2.4 0.17*
Anaesthesia duration/min 84.3±4.3 83.1±3.5 85±5.6 85.6±5 0.31*
Morphine consumption/mg 14.1±2.1 8.4±2.3 4.3±0.9 0.3±0.2 <0.001
Breastfeeding time/min 58±5.5 42.6±5.4 31.9±6.6 25.8±3.5 <0.001
Nausea (n%) 8 (34.8%) 3 (13%) 2 (8.7%) 0.00 0.006**
Vomiting (n%) 6 (26.1%) 2 (8.7%) 1 (4.3%) 0.00 0.01**
Shivering (n%) 15 (65.2%) 8 (34.8%) 4 (17.4%) 0.00 0.00***
Retention (n%) 7 (30%) 4 (17.4%) 2 (8.7%) 0.00 0.02**
Drowsiness (n%) 2 (8.7%) 3 (13%) 9 (39.1%) 8 (34.8%) 0.03**
Dizziness (n%) 3 (13%) 5 (21.7%) 9 (39.1%) 5(21.7%) 0.2*
Pruritus (n%) 3 (13%) 4 (17.4%) 2 (8.7%) 2 (8.7%) 0.7*

Statistical test: Mean, Standard deviation, frequencies

*Not significant, ** Significant, *** Highly significant